Furthermore, we observed a significant positive correlation between IGF2BP1 and immune cells, specifically natural killer T cells, central memory CD4 T cells, and activated CD8 T cells, which has implications for depression immunotherapy. Here, IGF2BP1 is linked to depressive symptom measurement.